Symptomatic Pneumonitis with Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
JTO Clinical and Research Reports(2024)
Key words
Immunotherapy,Radiotherapy,Durvalumab,Pulmonary toxicity,Locally advanced NSCLC
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined